Literature DB >> 9202079

Vitamin A regulates genes involved in hepatic gluconeogenesis in mice: phosphoenolpyruvate carboxykinase, fructose-1,6-bisphosphatase and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase.

D J Shin1, M M McGrane.   

Abstract

We examined the effects of vitamin A deficiency and all-trans retinoic acid (RA) supplementation on regulation of three important genes in hepatic gluconeogenesis: the genes for phosphoenolpyruvate carboxykinase (PEPCK), fructose-1,6-bisphosphatase (Fru-1,6-P2ase) and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (6-PF-2-K/Fru-2,6-P2ase). Mice were made vitamin A deficient in the second generation by initiating a vitamin A-deficient diet on d 10 of gestation. At 7 wk of age, vitamin A-deficient mice were treated with all-trans RA or vehicle alone and killed for RNA analysis. In liver, vitamin A deficiency resulted in PEPCK mRNA levels that were 74% lower and 6-PF-2-K/Fru-2,6-P2ase mRNA levels that were 42% lower than the respective mRNA measured in control mice. The Fru-1,6-P2ase mRNA abundance was not affected by vitamin A deficiency. The decrease in hepatic PEPCK and 6-PF-2-K/Fru-2,6-P2ase mRNA levels was reversed by treatment with all-trans RA within 3 h of administration. In mice fed the control diet, food deprivation for 15 h resulted in PEPCK mRNA levels that were 3.5-fold higher, Fru-1,6-P2ase mRNA levels that were 2-fold higher, and 6-PF-2-K/Fru-2,6-P2ase mRNA levels that were 3.4-fold higher than in fed mice. Vitamin A-deficient mice did not respond to food deprivation with induced PEPCK mRNA levels, whereas 6-PF-2-K/Fru-2,6-P2ase and Fru-1,6-P2ase mRNA levels were induced. The pattern of 6-PF-2-K/Fru-2,6-P2ase mRNA abundance with vitamin A deficiency and food deprivation was complex and different from that for either PEPCK or Fru-1,6-P2ase transcripts. The cAMP-responsiveness of the PEPCK gene in vitamin A-deficient mice was tested. Vitamin A deficiency caused a significant reduction in cAMP stimulation of PEPCK mRNA levels in liver. These results in the whole animal indicate that vitamin A regulation of the hepatic PEPCK gene is physiologically important; without adequate vitamin A nutriture, stimulation of the PEPCK gene by food deprivation or cAMP treatment is inhibited in the liver.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9202079     DOI: 10.1093/jn/127.7.1274

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  5 in total

1.  Increased adiposity in the retinol saturase-knockout mouse.

Authors:  Alexander R Moise; Glenn P Lobo; Bernadette Erokwu; David L Wilson; David Peck; Susana Alvarez; Marta Domínguez; Rosana Alvarez; Chris A Flask; Angel R de Lera; Johannes von Lintig; Krzysztof Palczewski
Journal:  FASEB J       Date:  2009-11-25       Impact factor: 5.191

2.  Retinaldehyde dehydrogenase 1 coordinates hepatic gluconeogenesis and lipid metabolism.

Authors:  Florian W Kiefer; Gabriela Orasanu; Shriram Nallamshetty; Jonathan D Brown; Hong Wang; Philip Luger; Nathan R Qi; Charles F Burant; Gregg Duester; Jorge Plutzky
Journal:  Endocrinology       Date:  2012-05-03       Impact factor: 4.736

3.  Changes in retinoid metabolism and signaling associated with metabolic remodeling during fasting and in type I diabetes.

Authors:  Alla V Klyuyeva; Olga V Belyaeva; Kelli R Goggans; Wojciech Krezel; Kirill M Popov; Natalia Y Kedishvili
Journal:  J Biol Chem       Date:  2021-01-22       Impact factor: 5.157

4.  Genome-wide analysis of FoxO1 binding in hepatic chromatin: potential involvement of FoxO1 in linking retinoid signaling to hepatic gluconeogenesis.

Authors:  Dong-Ju Shin; Pujan Joshi; Seung-Hyun Hong; Kathleen Mosure; Dong-Guk Shin; Timothy F Osborne
Journal:  Nucleic Acids Res       Date:  2012-10-12       Impact factor: 16.971

5.  Physiogenomic comparison of human fat loss in response to diets restrictive of carbohydrate or fat.

Authors:  Richard L Seip; Jeff S Volek; Andreas Windemuth; Mohan Kocherla; Maria Luz Fernandez; William J Kraemer; Gualberto Ruaño
Journal:  Nutr Metab (Lond)       Date:  2008-02-06       Impact factor: 4.169

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.